Lynthera Corporation
Monday, June 03, 2024
Ophthalmology
Company Presentation Theater 3
Lynthera is a biomedical company specializing in the research and development of drug delivery and formulation technology. We have created a novel technology platform for the controlled release of ocular therapeutics. This technology has been demonstrated through our development of a drug delivery contact lens (DDCL) product for the treatment of glaucoma, dry eye, and ocular allergy.
Company Website:
http://www.lynthera.com
Lead Product in Development:
Drug-eluting contact lens for dry eye
Number Of Unlicensed Products (For Which You Are Seeking Partners):
5
Company HQ City
Lancaster
Company HQ State
Pennsylvania
Company HQ Country
United States
CEO/Top Company Official
Jeff Yang
Development Phase of Primary Product
Pre-Clinical
Primary Speaker
)
)
)
)
)
)
){kind=logo}
){kind=logo}
.png/fit-in/500x500/filters:no_upscale())